American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6402)
  2. Solid Tumor Oncology Division (5540)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1638)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1354)
  10. Hematologic Malignancies, Division of (1282)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2584)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6402)
  2. Solid Tumor Oncology Division (5540)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1638)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (291)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8707)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (10)

More Publications

Results (9183)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The PRIME-CUT study: A single-arm phase 2 study of ADT with PD-1 blockade and docetaxel in men with metastatic hormone-sensitive prostate cancer
    Meeting Abstract

    Hawley, J. E.; Dallos, M.; Lim, E. A.; Runcie, K.; Hu, J.; Lowy, I.; Drake, C. G.; Stein, M. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1/2 study of bay 18953444 (elimusertib) in pediatric patients with relapsed or refractory solid tumors: Initial report of the phase 1 results of PEPN2112
    Meeting Abstract

    Ortiz, M. V.; Glade Bender, J. L.; Minard, C. G.; Liu, X.; Denic, K. Z.; Reid, J. M.; Militano, O.; Church, A. J.; Kentsis, A.; Reynolds, C. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Negative selection of patients (pts) with HER2-positive and RAS wild-type (wt) metastatic colorectal cancer (mCRC) receiving dual HER2 blockade
    Meeting Abstract

    Randon, G.; Nakamura, Y.; Yaeger, R.; Lonardi, S.; Cremolini, C.; Elez, E.; Nichetti, F.; Ghelardi, F.; Nasca, V.; Bergamo, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes in patients with radiation associated rectal adenocarcinoma
    Meeting Abstract

    Omer, D. M. R.; Verheij, F. S.; Luthra, A.; Rosen, R.; Thompson, H. M.; Romesser, P. B.; Paty, P.; Garcia-Aguilar, J.; Sanchez-Vega, F.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Analysis of androgen receptor dynamics through immunofluorescent staining of circulating tumor cells in castration-resistant prostate cancer
    Meeting Abstract

    Barnett, E.; Gupta, S.; Erazo, T.; Lam, E.; Carbone, E.; Zanone, M.; Nystrom, L.; Gajar, R. N.; Wenstrup, R.; Scher, H. I.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real world treatment patterns and survival by germline BRCA (gBRCA) mutation status in patients with HER2-negative early breast cancer (eBC) in the US community oncology setting: A retrospective observational study
    Meeting Abstract

    Andersen, J. C.; Earla, J. R.; Fulcher, N.; Ndukum, J.; Robert, N. J.; Robson, M. E.; Li, W.; Mejia, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer
    Meeting Abstract

    Liu, B.; Shen, S.; Omoyiola, O. Z.; Odujoko, O. O.; Sharma, A.; Ogunleye, G. S.; Owoade, I. A.; Olasehinde, O.; Wuraola, F. O.; Ntiamoah, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Integrating technology to support data management abstraction of adverse events (AE) and concomitant medications (ConMed) from the electronic health record (EHR) to sponsor electronic data capture (EDC) systems using design thinking (DT) methodology
    Meeting Abstract

    Yuravlivker, L.; Buckley, M. T.; Bouvier, N.; Jeevarathnam, S.; Lazan, S.; Panchal, R.; McKellop, M.; Lengfellner, J. M.; Terzulli, S. L.; Sabbatini, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save